Does OSIMERTINIB Cause Alopecia? 176 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 176 reports of Alopecia have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.6% of all adverse event reports for OSIMERTINIB.
176
Reports of Alopecia with OSIMERTINIB
0.6%
of all OSIMERTINIB reports
6
Deaths
32
Hospitalizations
How Dangerous Is Alopecia From OSIMERTINIB?
Of the 176 reports, 6 (3.4%) resulted in death, 32 (18.2%) required hospitalization, and 5 (2.8%) were considered life-threatening.
Is Alopecia Listed in the Official Label?
Yes, Alopecia is listed as a known adverse reaction in the official FDA drug label for OSIMERTINIB.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Alopecia?
DOCETAXEL (29,347)
METHOTREXATE (14,360)
ADALIMUMAB (13,726)
ETANERCEPT (11,390)
INFLIXIMAB (10,374)
LEFLUNOMIDE (10,267)
RITUXIMAB (10,119)
ABATACEPT (10,043)
TOCILIZUMAB (9,680)
HYDROXYCHLOROQUINE (9,653)
Which OSIMERTINIB Alternatives Have Lower Alopecia Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN